ArticleCell regeneration (London, England)2025
Schwann cells modified to secrete MANF is a potential cellular therapy for peripheral nerve regeneration.
Article in Cell regeneration (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective therapies for peripheral nerve repair are still lacking despite active research in this field over the past years. The limited knowledge of biomolecules that equally promote axon regeneration and glial cell dynamics, which are critical for nerve regeneration, poses a major challenge in developing effective therapies. Here, we showed that the neurotrophic factor mesencephalic astrocyte-derived neurotrophic factor (MANF) equally promotes axon regeneration and glial cell dynamics favorable for nerve regeneration. Using adult rodent models, we showed that the endogenous expression of MANF is restricted to non-peptidergic sensory neurons. However, supplementation of exogenous MANF promoted the growth of all subtypes of adult sensory neurons. We also demonstrated that exogenous MANF promotes the proliferation and migration of adult primary Schwann Cells (SCs). Furthermore, we showed that local and repeated administration of MANF to injured nerves promotes axon regeneration in mice models. Finally, we devised a therapeutic approach by programming nerve-resident SCs to locally and continuously deliver MANF to injured nerves and showed that this approach improves axon regeneration. Overall, this work developed a therapeutic approach by harnessing the power of SCs as a local delivery system for MANF for nerve repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.